Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BIIB | RPRX | BNTX | ||
| Company | Biogen Inc | Royalty Pharma Plc Cl A | Biontech Se ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 179.54 | 49.55 | 102.15 | ||
| High | 183.69 | 50.08 | 105.08 | ||
| Low | 178.72 | 49.52 | 102.10 | ||
| Latest | 182.93 | 49.88 | 104.36 | ||
| Change | +5.58 | -0.12 | +1.44 | ||
| % Change | +3.15% | -0.24% | +1.40% | ||
| Volume | 342,498 | 749,217 | 295,561 | ||
| 20-Day Average Volume | 1,242,460 | 2,741,891 | 761,455 | ||
| Previous Close | 177.35 | 50.00 | 102.92 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 180.69 | 47.77 | 92.81 | ||
| 20-Day Raw Stochastic | 60.59% | 94.64% | 96.53% | ||
| 20-Day Relative Strength | 50.98 | 65.72 | 60.67 | ||
| Weighted Alpha | +48.52 | +58.72 | +2.92 | ||
| Today's Opinion | 40% Buy | 100% Buy | 8% Sell | ||
| Previous Opinion | 8% Buy | 100% Buy | 24% Sell | ||
| Last Month's Opinion | 64% Buy | 88% Buy | 56% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.74% since 04/13/26 | +2.85% since 04/13/26 | +7.84% since 04/13/26 | ||
| Low | 174.85 on 04/16/26 | 48.08 on 04/15/26 | 95.36 on 04/14/26 | ||
| High | 183.69 on 04/20/26 | 50.08 on 04/20/26 | 104.98 on 04/17/26 | ||
| 1-Month | |||||
| %Chg | +0.83% since 03/20/26 | +9.81% since 03/20/26 | +16.81% since 03/20/26 | ||
| Low | 168.64 on 04/06/26 | 45.04 on 03/23/26 | 84.78 on 03/30/26 | ||
| High | 192.27 on 03/26/26 | 50.08 on 04/20/26 | 104.98 on 04/17/26 | ||
| 3-Month | |||||
| %Chg | +10.63% since 01/20/26 | +27.42% since 01/20/26 | -1.21% since 01/20/26 | ||
| Low | 165.31 on 01/21/26 | 39.02 on 01/21/26 | 79.52 on 03/10/26 | ||
| High | 202.41 on 02/06/26 | 50.08 on 04/20/26 | 124.00 on 01/22/26 | ||
| 6-Month | |||||
| %Chg | +24.78% since 10/20/25 | +35.98% since 10/20/25 | -3.40% since 10/20/25 | ||
| Low | 138.00 on 10/30/25 | 35.92 on 10/28/25 | 79.52 on 03/10/26 | ||
| High | 202.41 on 02/06/26 | 50.08 on 04/20/26 | 124.00 on 01/22/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 26,027,710 | 28,842,850 | 26,026,820 | ||
| Shares Outstanding, K | 146,759 | 576,857 | 252,884 | ||
| Annual Sales | 9,890,600,000 | 2,378,190,000 | 3,247,010,000 | ||
| Annual Net Income | 1,292,900,000 | 770,950,000 | -1,285,380,000 | ||
| Last Quarter Sales | 2,279,400,000 | 621,990,000 | 982,920,000 | ||
| Last Quarter Net Income | -48,900,000 | 214,210,000 | -374,920,000 | ||
| 60-Month Beta | 0.16 | 0.39 | 1.58 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.99 on 02/06/26 | 1.46 on 02/11/26 | -0.38 on 03/10/26 | ||
| Latest Earnings Date | 04/29/26 | 05/06/26 | 05/04/26 | ||
| Most Recent Dividend | N/A | 0.235 on 02/20/26 | 3.084 on 06/02/22 | ||
| Next Ex-Dividends Date | N/A | 05/15/26 | 06/02/22 | ||
| Ratios | |||||
| Price/Earnings ttm | 11.51 | 10.04 | 0.00 | ||